The epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase that is commonly upregulated in various cancers, such as non-small–cell lung cancer, metastatic colorectal cancer, head and neck cancer, and breast cancer. This evidence concerns the gene EGFR and breast carcinoma.